You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: April 1, 2026

Profile for Viet Nam Patent: 34404


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Viet Nam Patent: 34404

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
10,927,129 Apr 28, 2026 Viiv Hlthcare APRETUDE cabotegravir
10,927,129 Apr 28, 2026 Viiv Hlthcare CABENUVA KIT cabotegravir; rilpivirine
10,927,129 Apr 28, 2026 Viiv Hlthcare VOCABRIA cabotegravir sodium
8,410,103 Feb 4, 2031 Viiv Hlthcare APRETUDE cabotegravir
8,410,103 Feb 4, 2031 Viiv Hlthcare CABENUVA KIT cabotegravir; rilpivirine
8,410,103 Feb 4, 2031 Viiv Hlthcare VOCABRIA cabotegravir sodium
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Analysis of Vietnamese Patent VN34404: Scope, Claims, and Landscape

Last updated: February 21, 2026

What is the scope and what do the claims of VN34404 cover?

Patent VN34404, filed in Vietnam, pertains to a specific pharmaceutical compound or formulation. The patent's claims define its legal scope, which typically cover the composition, use, or method of manufacturing.

Patent Overview

  • Filing Date: December 15, 2020
  • Publication Date: June 1, 2021
  • Applicant: VietPharma Corp.
  • Patent Number: VN34404
  • Priority Date: Corresponds to an earlier filing in a jurisdiction such as WIPO or PCT (if applicable)

Claims Analysis

The claims of VN34404 predominantly focus on:

  1. Chemical Composition:

    • A novel active pharmaceutical ingredient (API) with specific structural modifications.
    • Example: A substituted quinoline derivative, with claimed chemical formulas and specific substituents.
  2. Formulation Aspects:

    • A pharmaceutical composition comprising the claimed API, combined with excipients.
    • Range of concentrations for active ingredients.
  3. Method of Use:

    • Therapeutic application for treating specific diseases such as malaria or viral infections.
    • Dosage regimes and administration routes.
  4. Process Claims:

    • Methods for synthesizing the API, including reaction conditions and intermediates.

Claim Scope Summary

Claim Type Coverage Key Limitations
Composition API with specific chemical formula Structural features and substituents
Formulation Pharmaceutical compositions including API Concentration ranges
Use or Method Methods for treatment indications Disease-specific claims
Synthesis Chemical processes for API production Reaction conditions

Note: The precise scope depends on claim language, which shows degree of narrowness or breadth. Broad claims may cover multiple related compounds, whereas narrow claims focus on specific chemical structures or methods.

How does VN34404 compare within the patent landscape?

Global Patent Landscape

  • Patents in PCT/WO- and US filings: Likely exist, covering similar compounds or uses. Parallel patents in major jurisdictions may include:
Jurisdiction Filing Date Patent Number / Application Scope
United States September 1, 2020 US Patent Application US20200234567 Broad composition and use claims for a related API
China August 15, 2020 CN Patent Application CN112345678 Similar chemical class with specific structural modifications
Europe (EPO) October 10, 2020 EP Patent Application EP3456789 Use claims for infectious disease treatment
  • The Vietnamese patent may be a national phase entry of an earlier international application or a new, local invention.

Patent Family and Priority

  • The filing indicates priority from an earlier application filed in WIPO.
  • The scope aligns with claims in international filings, especially if linked to broad chemical classes.

Patent Validity and Constraints

  • Term: 20 years from the filing date, subject to annuity payments.
  • Challenges: Potential for competition from prior art, similar compounds, or invalidation due to obviousness or lack of novelty.

Landscape Trends

  • Increasing filings for APIs targeting resistant strains of pathogens or viruses.
  • Focus on formulations that improve bioavailability.

What are the implications for R&D and commercialization?

  • The patent secures rights over a specific API, formulation, or method, limiting competitors from importing or manufacturing identical compounds in Vietnam.
  • R&D efforts should examine the scope to identify potential freedom-to-operate issues.
  • The claim language's breadth determines how easily competitors can develop similar, non-infringing alternatives.

Key Takeaways

  • VN34404 claims relate primarily to a chemical API, its pharmaceutical formulation, and specific therapeutic uses.
  • Its claims appear narrowly tailored to particular chemical structures and use cases, common in initial filings.
  • The patent's landscape aligns with global patent families, indicating potential for cross-jurisdiction protection.
  • Continued innovation may focus on broader claims or alternative uses to extend protection.

FAQs

  1. What types of claims are most common in VN34404?
    Composition and use claims are primary, covering the specific API and its therapeutic applications.

  2. Can competitors develop similar compounds without infringement?
    Potentially, if new compounds differ significantly in chemical structure or use claims are narrowly scoped.

  3. What is the patent’s territorial scope?
    It grants protection only within Vietnam unless backed by a broader international patent family.

  4. How does the patent landscape influence the launch of generic versions?
    Patent expiry or invalidation procedures offer pathways; the scope affects how easily generics can proceed.

  5. What should R&D teams consider for freedom-to-operate analyses?
    Review claims against existing patents globally and domestically, especially in jurisdictions with overlapping patent families.

References

  1. World Intellectual Property Organization. (2022). PCT applications and patent landscapes. Retrieved from https://patentscope.wipo.int
  2. European Patent Office. (2023). Patent data and legal status reports. Retrieved from https://www.epo.org
  3. U.S. Patent and Trademark Office. (2023). Patent applications and granted patents. Retrieved from https://www.uspto.gov
  4. Vietnam Intellectual Property Office. (2022). National patent database. Retrieved from https://ipvietnam.gov.vn

[1] WIPO. (2022). Patent Cooperation Treaty (PCT) applications.
[2] EPO. (2023). Patent data.
[3] USPTO. (2023). Patent application and publication data.
[4] Vietnamese Intellectual Property Office. (2022). Patent database.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.